Skip to main content
Clinical Trials/SLCTR/2012/008
SLCTR/2012/008
Recruiting
未知

A study to determine the therapeutic value of the prokinetic drug- domperidone to improve gastric motility in children with abdominal pain predominant functional gastrointestinal disorders (FGD)

none0 sitesTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Abdominal pain predominant functional gastrointestinal disorders in children
Sponsor
none
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
none

Eligibility Criteria

Inclusion Criteria

  • Age between 5\-12 years
  • Children who fulfil the Rome III criteria for abdominal pain related FGD
  • Children with abdominal pain at least once per week for at least 2 months prior to diagnosis
  • Pain severity more than 25% on visual analogue scale pain interrupt the activities of the child (e.g. sleep, play, schooling etc)
  • Written informed consent from parents or legally\-accepted guardians

Exclusion Criteria

  • Clinical or laboratory evidence suggesting organic pathology
  • Chronic medical or surgical disease other than FGD
  • Long\-term medication for any illness other than FGD
  • Previous abdominal surgery except appendectomy
  • Use of prokinetic drugs or any other drugs that can alter gastrointestinal motility during the within 30 days prior to the diagnosis

Outcomes

Primary Outcomes

Not specified

Similar Trials